natgillin/translations-raw huggingface dataset:
Farmakoterapeutisk klassifikation: Antiparkinsonmidler, ATC-kode: N04BX01 Virkningsmekanisme:
Pharmaco-therapeutic group: Anti-Parkinson drugs, other dopaminergic agents, ATC code: NO4BX01 Mechanism of action
Farmakoterapeutisk klassifikation: Antiprotozo-midler, malariamidler, artemisinin og derivater, kombinationer, ATC-kode: P01BF05
Pharmacotherapeutic group: Antiprotozoals, antimalarials, artemisinin and derivatives, combinations, ATC code: P01BF05.
Farmakoterapeutisk klassifikation: Antithrombosemiddel - direkte thrombininhibitor (ATC-kode: B01AE02)
Pharmacotherapeutic group: Antithrombotic agent – direct thrombin inhibitor, ATC Code: B01AE02
Farmakoterapeutisk klassifikation: antithrombosemidler, trombocytfunktionshæmmende midler eksklusive heparin, ATC-kode: B01AC-04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapeutisk klassifikation: antithrombotisk middel, ATC-kode: B01AD07 Virkningsmekanisme
Pharmacotherapeutic group: antithrombotic agent, ATC Code: B01AD07 Mechanism of action
Farmakoterapeutisk klassifikation: Antitrombosemidler, heparin-gruppen.
Pharmacotherapeutic group: Antithrombotic agents, heparin group.
Farmakoterapeutisk klassifikation: Antitrombotisk stof, ATC-kode: B 01 AD11 Virkningsmekanisme
Pharmacotherapeutic group: Antithrombotic agents, ATC code: B01A D11 Mechanism of action
Farmakoterapeutisk klassifikation: antivirale lægemidler til systemisk anvendelse ; antivirale lægemidler til behandling af hiv-infektion, kombinationsbehandling, ATC-kode: J05AR16
Pharmacotherapeutic group: Antivirals for systemic use; antivirals for treatment of HIV infections, combinations, ATC code: J05AR16
Farmakoterapeutisk klassifikation: antivirale lægemidler til systemisk anvendelse, andre antivirale lægemidler, ATC-kode: J05AX08
Pharmacotherapeutic group: antivirals for systemic use, other antivirals, ATC code: J05AX08.
Farmakoterapeutisk klassifikation: Antivirale midler til systemisk brug, nucleosid og nucleotid revers transkriptase-hæmmere, ATC-kode: JO5AF04.
Pharmacotherapeutic group: antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors, ATC code: J05AF04
Farmakoterapeutisk klassifikation: Antivirale midler til systemisk brug, proteasehæmmere, ATC- kode: J05AE12
Pharmacotherapeutic group: antivirals for systemic use, protease inhibitors, ATC code: J05AE12
Farmakoterapeutisk klassifikation: Antivirale midler til systemisk brug; direkte virkende antivirale midler, ATC-kode: J05AX68
Pharmacotherapeutic group: Antivirals for systemic use; Direct-acting antiviral, ATC code: J05AX68
Farmakoterapeutisk klassifikation: Antiviralt middel til systemisk brug, nukleosider og nukleotider ekskl. revers transkriptase-hæmmere, ATC kode: J05AB12
Pharmacotherapeutic group: Antivirals for systemic use, nucleosides and nucleotides excluding reverse transcriptase inhibitors, ATC code: J05AB12
Farmakoterapeutisk klassifikation: Antiviralt middel, ATC kode J05AE01.
Pharmaco-therapeutic group: Antiviral agent, ATC code J05A E01
Farmakoterapeutisk klassifikation: Antiviralt middel, ATC-kode: J05AE01.
Pharmaco-therapeutic group: Antiviral agent, ATC code J05A E01
Farmakoterapeutisk klassifikation: Anæstetika, andre lokale anæstetika, ATC-kode: N01BX04 Virkningsmekanisme
Pharmacotherapeutic group: Anaesthetics, other local anaesthetics, ATC code: N01BX04 Mechanism of action
Farmakoterapeutisk klassifikation: ATC-kode: D03BA03 bromelains
Pharmacotherapeutic group: ATC code: D03BA03 bromelains
Farmakoterapeutisk klassifikation: Bakterielle vacciner, ATC-kode: J07AE01 Virkningsmekanisme
Pharmacotherapeutic group: Bacterial vaccines, ATC-code: J07AE01 Mechanism of action
Farmakoterapeutisk klassifikation: Behandling af hyperphosphatæmi.
Pharmacotherapeutic group: Treatment of hyperphosphataemia.
Farmakoterapeutisk klassifikation: Blodkoagulationsfaktorer, ATC kode: B02B D08 Virkningsmekanisme
Pharmacotherapeutic group: Blood coagulation factors, ATC code: B02BD08 Mechanism of action
Farmakoterapeutisk klassifikation: Blodkoagulationsfaktorer, ATC kode: B02BD08 Virkningsmekanisme
Pharmacotherapeutic group: Blood coagulation factors, ATC code: B02BD08 Mechanism of action
Farmakoterapeutisk klassifikation: Blodplade-aggregationshæmmere excl.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl.
Farmakoterapeutisk klassifikation: Blodplade-aggregationshæmmere excl. heparin.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl.
Farmakoterapeutisk klassifikation: Blødgørende og hudbeskyttende midler, midler beskyttende mod UV-stråling, systemisk brug, ATC-kode: D02BB02
Pharmacotherapeutic group: Emollients and protectives, protectives against UV radiation for systemic use; ATC code: D02BB02
Farmakoterapeutisk klassifikation: Calciumhomeostase, Parathyreoideahormoner og -analoger, ATC- kode: H05AA02.
Pharmaco-therapeutic group: Calcium homeostasis, parathyroid hormones and analogues, ATC code: H05 AA02.
Farmakoterapeutisk klassifikation: cytokiner, ATC-kode: L03AA02
Pharmacotherapeutic group: cytokines ATC code: L03AA02
Farmakoterapeutisk klassifikation: cytokiner, ATC-kode: L03AA02
Pharmacotherapeutic group: cytokines, ATC code: L03AA02
Farmakoterapeutisk klassifikation: Cytostatikum (antimetabolit), ATC kode: L01BC06 Capecitabin er et non-cytotoksisk fluorpyrimidincarbamat, som virker som en oral administreret prækursor for det cytotoksiske 5- fluoruracil (5-FU).
Pharmacotherapeutic group: cytostatic (antimetabolite), ATC code: L01BC06 Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU).
Farmakoterapeutisk klassifikation: Cytostatikum (antimetabolitter), ATC kode: L01BC06
Pharmacotherapeutic group: cytostatics (antimetabolites), ATC code: L01BC06
Farmakoterapeutisk klassifikation: Cytotoksiske stoffer (antracykliner og relaterede substanser), ATC- kode: L01DB01.
Pharmacotherapeutic group: Cytotoxic agents (anthracyclines and related substances), ATC code: L01DB01.
Farmakoterapeutisk klassifikation: Dermatologiske midler, andre, ATC-kode: D11AH01 Virkningsmekanisme og farmakodynamisk virkning
Pharmacotherapeutic group: Other dermatologicals, ATC code: D11AH01 Mechanism of action and pharmacodynamic effects
Farmakoterapeutisk klassifikation: Dermatologiske midler, andre, ATC-kode: D11AX14 Virkningsmekanisme og farmakodynamisk effekt
Pharmacotherapeutic group: Other dermatologicals, ATC code: D11AX14 Mechanism of action and pharmacodynamic effects
Farmakoterapeutisk klassifikation: diagnostisk radioaktivt lægemiddel, centralnervesystem, ATC- kode: V09AX05
Pharmacotherapeutic group: diagnostic radiopharmaceutical, central nervous system, ATC code: V09AX05
Farmakoterapeutisk klassifikation: Diagnostisk radioaktivt lægemiddel, centralnervesystemet, ATC- kode: V09AX06
Pharmacotherapeutic group: diagnostic radiopharmaceutical, central nervous system; ATC code: V09AX06
Farmakoterapeutisk klassifikation: diazepiner, oxazepiner og thiazepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code: N05AH03.
Farmakoterapeutisk klassifikation: Digestiva, incl. enzymer; enzympræparater; ATC-kode: A09AA02 Virkningsmekanisme
Pharmacotherapeutic group: Digestives, incl. enzymes, Enzyme preparations, ATC code: A09AA02 Mechanism of action
Farmakoterapeutisk klassifikation: Direkte faktor Xa-hæmmere, ATC-kode: B01AF01 Virkningsmekanisme
Pharmacotherapeutic group: Direct factor Xa inhibitors, ATC code: B01AF01 Mechanism of action
Farmakoterapeutisk klassifikation: Direkte virkende antivirale midler, ATC-kode: endnu ikke tildelt
Pharmacotherapeutic group: Direct acting antiviral, ATC code: not yet assigned
Farmakoterapeutisk klassifikation: Direkte virkende antivirale midler, ATC-kode: J05AX15 Virkningsmekanisme
Pharmacotherapeutic group: Direct-acting antiviral; ATC code: J05AX15 Mechanism of action
Farmakoterapeutisk klassifikation: Direkte virkende antivirale midler, ATC-kode: J05AX65 Virkningsmekanisme
Pharmacotherapeutic group: Direct-acting antiviral, ATC code: J05AX65 Mechanism of action
Farmakoterapeutisk klassifikation: Direkte virkende antivirale stoffer, nukleosider og nukleotider (eksklusive reverse transcriptase-hæmmere), ATC-kode: J05AB04.
Pharmacotherapeutic group: Direct acting antivirals, nucleosides and nucleotides (excl.reverse transcriptase inhibitors), ATC code: J05AB04.
Farmakoterapeutisk klassifikation: Diuretika, vasopressin-antagonister, ATC-kode C03XA01
Pharmacotherapeutic group: Diuretics, vasopressin antagonists, ATC code C03XA01
Farmakoterapeutisk klassifikation: Div. midler til fordøjelsesorganer og stofskifte, ATC-kode: A16A X03.
Pharmacotherapeutic group: various alimentary tract and metabolism products, ATC code: A16A X03.
Farmakoterapeutisk klassifikation: Echinocandiner (systemiske svampeinfektioner), ATC-kode: J02AX06.
Pharmacotherapeutic group: – Antimycotics for systemic use, other antimycotics for systemic use.ATC code: JO2AX06
Farmakoterapeutisk klassifikation: Encefalitisvaccine.
Pharmacotherapeutic group: Encephalitis vaccines.
Farmakoterapeutisk klassifikation: endnu ikke tildelt, ATC kode: endnu ikke tildelt Virkningsmekanisme
Pharmacotherapeutic group: not yet assigned, ATC code: not yet assigned Mechanism of action
Farmakoterapeutisk klassifikation: Endnu ikke tildelt, ATC kode: Endnu ikke tildelt.
Pharmacotherapeutic group: Not yet assigned, ATC code: Not yet assigned
Farmakoterapeutisk klassifikation: Endnu ikke tildelt, ATC-kode: Endnu ikke tildelt Virkningsmekanisme
Pharmacotherapeutic group: Not yet assigned, ATC code: Not yet assigned Mechanism of Action
Farmakoterapeutisk klassifikation: endnu ikke tildelt, ATC-kode: endnu ikke tildelt.
Pharmacotherapeutic group: not yet assigned, ATC code: not yet assigned.
Farmakoterapeutisk klassifikation: Endokrin behandling, antiøstrogener, ATC-kode: L02BA03 Virkningsmekanisme og farmakodynamisk virkning
Pharmacotherapeutic group: Endocrine therapy, Anti-estrogens, ATC code: L02BA03 Mechanism of action and pharmacodynamic effects
Farmakoterapeutisk klassifikation: Endokrin terapi, andre hormonantagonister og beslægtede stoffer, ATC- kode: L02BX02
Pharmacotherapeutic group: Endocrine therapy, Other hormone antagonists and related agents, ATC code: L02BX02
Farmakoterapeutisk klassifikation: enzymer-imiglucerase (rekombinant makrofagrettet - glucocerebrosidase), ATC-kode: A16AB02.
Pharmacotherapeutic group: Enzymes-Imiglucerase (recombinant macrophage targeted - glucocerebrosidase), ATC code: A16AB02.
Farmakoterapeutisk klassifikation: Fordøjelsesorganer og stofskifte, andre stofskiftesygdomme, ATC- kode: A16AA06
Pharmacotherapeutic group: Other alimentary tract and metabolism products, ATC code: A16AA06.
Farmakoterapeutisk klassifikation: Fordøjelsesorganer og stofskifte, Andre stofskiftesygdomme, ATC- kode: A16AX03.
Pharmacotherapeutic group: Other alimentary tract and metabolism products, various alimentary tract and metabolism products, ATC code: A16AX03.
Farmakoterapeutisk klassifikation: forskellige fordøjelseskanals- og metabolismeprodukter, ATC- kode: A16A X03.
Pharmacotherapeutic group: various alimentary tract and metabolism products, ATC code: A16A X03.
Farmakoterapeutisk klassifikation: Hepatitis-vacciner ATC-kode: J07BC20
Pharmacotherapeutic group: Hepatitis vaccines, ATC code: J07BC20.
Farmakoterapeutisk klassifikation: Hepatitisvacciner ATC-kode: J07BC20
Pharmaco-therapeutic group: Hepatitis vaccines, ATC code: J07BC20.
Farmakoterapeutisk klassifikation: Hepatitisvacciner ATC-kode: J07BC20
Pharmacotherapeutic group: Hepatitis vaccines, ATC code: J07BC20.
Farmakoterapeutisk klassifikation: Hjerteterapi, andre hjertemidler, ATC-kode: C01EB21 Virkningsmekanisme
Pharmacotherapeutic group: Cardiac therapy, other cardiac preparations, ATC code: C01EB21 Mechanism of action
Farmakoterapeutisk klassifikation: Hjerteterapi, antiarytmikum klasse III, ATC-kode: C01BD07 Virkningsmekanisme
Pharmacotherapeutic group: cardiac therapy, antiarrhythmic class III, ATC code: C01BD07 Mechanism of action
Farmakoterapeutisk klassifikation: Hurtigt virkende human insulin-analog.
Pharmacotherapeutic group : Fast-acting human insulin analogue.
Farmakoterapeutisk klassifikation: Hurtigt virkende human insulin-analog.
Pharmacotherapeutic group :Fast-acting human insulin analogue.
Farmakoterapeutisk klassifikation: hæmostase til lokalbrug, ATC-kode: B02BC30, kombinationer Virkningsmekanisme
Pharmacotherapeutic group: local haemostatics, ATC code: B02BC30 combinations Mechanism of action
Farmakoterapeutisk klassifikation: Hæmostatika, blodkoagulationsfaktor VIII, ATC-kode: B02BD02 Virkningsmekanisme
Pharmacotherapeutic group: antihemorrhagics: blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapeutisk klassifikation: Hæmostatika: blodkoagulationsfaktorer, von Willebrand-faktor og koagulationsfaktor VIII i kombination.
Pharmacotherapeutic group: Antihaemorrhagics: Blood coagulation factors, von Willebrand factor and coagulation factor VIII in combination.
Farmakoterapeutisk klassifikation: Ikke relevant ATC kode: Ikke relevant }
Pharmacotherapeutic group: Not applicable ATC code: Not applicable
Farmakoterapeutisk klassifikation: Immunologiske lægemidler til heste, inaktiverede virale vacciner.
Pharmacotherapeutic group: Immunologicals for Equidae, inactivated viral vaccines.
Farmakoterapeutisk klassifikation: Immunologiske præparater til svinefamilien, levende bakterielle vacciner til svin.
Pharmacotherapeutic group: immunologicals for Suidae live bacterial vaccines for pigs.
Farmakoterapeutisk klassifikation: Immunosuppressiv, interleukin-hæmmere, ATC-kode: L04AC10 Virkningsmekanisme
Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC10 Mechanism of action
Farmakoterapeutisk klassifikation: Immunosuppressive stoffer, andre immunosuppressive stoffer, ATC-kode: L04AX05
Pharmacotherapeutic group: Immunosuppressants, other immunosuppressants, ATC code: L04AX05
Farmakoterapeutisk klassifikation: Immunsera og immunglobuliner, Specifikke immunglobuliner, ATC-kode: J06BB04
Pharmacotherapeutic group: Immune sera and immunoglobulins, Specific immunoglobulins, ATC code: J06BB04
Farmakoterapeutisk klassifikation: Immunstimulanter, interferoner, ATC-kode: L03AB11 Virkningsmekanisme
Pharmacotherapeutic group: Immunostimulants, interferons, ATC code: L03AB11 Mechanism of action
Farmakoterapeutisk klassifikation: Immunstimulerende midler, andre immunstimulerende midler, ATC- kode: endnu ikke tildelt.
Pharmacotherapeutic group: Immunostimulants, other immunostimulants , ATC code: not yet assigned
Farmakoterapeutisk klassifikation: Immunstimulerende midler, kolonistimulerende faktorer, ATC- kode: L03AA14
Pharmacotherapeutic group: Immunostimulants, Colony stimulating factors, ATC code: L03AA14
Farmakoterapeutisk klassifikation: immunsuppresiva, selektive immunsuppresiva, ATC-kode: L04AA06
Pharmacotherapeutic group: immunosuppressants, selective immunosuppressants, ATC code L04AA06
Farmakoterapeutisk klassifikation: Immunsuppressiva, calcineurinhæmmere, ATC-kode: L04AD02 Virkningsmekanisme
Pharmacotherapeutic group: Immunosuppressants, calcineurin inhibitors, ATC code: L04AD02 Mechanism of action
Farmakoterapeutisk klassifikation: immunsuppressiva, interleukinhæmmere, ATC-kode: L04AC01 Virkningsmekanisme
Pharmacotherapeutic group: immunosuppressants, interleukin inhibitors, ATC code: L04AC01 Mechanism of action
Farmakoterapeutisk klassifikation: Immunsuppressiva, interleukinhæmmere, ATC-kode: L04AC08 Virkningsmekanisme
Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC08 Mechanism of action
Farmakoterapeutisk klassifikation: Immunsuppressiva, selektive immunsuppressiva, ATC- kode: L04AA10.
Pharmacotherapeutic group: Immunosuppressants, selective immunosuppressants, ATC code: L04AA10.
Farmakoterapeutisk klassifikation: Immunsuppressiva, selektive immunsuppressiva, ATC- kode:L04AA10.
Pharmacotherapeutic group: Immunosuppressants, selective immunosuppressants, ATC code: L04AA10.
Farmakoterapeutisk klassifikation: immunsuppressiva, tumornekrosefaktor-alfa (TNFα)-hæ mmere, ATC-kode: L04AB02.
Pharmacotherapeutic group: immunosuppressants, tumour necrosis factor alpha (TNFα) inhibitors, ATC code: L04AB02.
Farmakoterapeutisk klassifikation: immunsuppressive midler, ATC kode L04AA06 Virkningsmekanisme
Pharmacotherapeutic group: immunosuppressive agents ATC code L04AA06 Mechanism of action
Farmakoterapeutisk klassifikation: immunsuppressive midler, ATC-kode L04AA06 Virkningsmekanisme
Pharmacotherapeutic group: immunosuppressive agents ATC code: LO4A A06 Mechanism of action
Farmakoterapeutisk klassifikation: Immunsupprimerende midler, interleukinhæmmere, ATC-kode: L04AC07
Pharmacotherapeutic group: Immunosupressants, Interleukin inhibitors; ATC code: L04AC07.
Farmakoterapeutisk klassifikation: infektionssygdomme, systemiske midler ATC-kode: J07BC01
Pharmacotherapeutic group: anti-infectious, ATC code: J07BC01
Farmakoterapeutisk klassifikation: Influenzavaccine, ATC-kode: J07BB02 Immunogenicitet
Pharmacotherapeutic group: Influenza vaccines, ATC code: J07BB02 Immunogenicity
Farmakoterapeutisk klassifikation: Influenzavaccine, ATC-kode: J07BB02 Virkning mod kulturbekræftet influenza
Pharmacotherapeutic group: Influenza vaccine, ATC Code: J07BB02 Efficacy against Culture-Confirmed Influenza
Farmakoterapeutisk klassifikation: Influenzavacciner, ATC-kode J07BB01 Dette afsnit beskriver den kliniske erfaring med H5N1-vaccinen.
Pharmacotherapeutic group: Influenza vaccines, ATC Code J07BB01 This section describes the clinical experience with the H5N1 vaccine.
Farmakoterapeutisk klassifikation: Influenzavacciner, ATC-kode J07BB01 Kliniske studier med Celvapan (H1N1)v giver aktuelt:
Pharmacotherapeutic group: Influenza vaccines, ATC Code J07BB01 Clinical studies with Celvapan (H1N1)v currently provide:
Farmakoterapeutisk klassifikation: Insuliner og analoger til injektion, hurtigtvirkende.
Pharmacotherapeutic group: Drugs used in diabetes insulins and analogues for injection, fast-acting.
Farmakoterapeutisk klassifikation: Insuliner og analoger til injektion, middellang virkningstid, ATC kode: A10AC01
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, intermediate-acting, ATC Code: A10AC01.
Farmakoterapeutisk klassifikation: Insuliner og analoger til injektion, middelvirkende kombineret med hurtigtvirkende ATC kode: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutisk klassifikation: Insuliner og analoger til injektion, middelvirkende kombineret med hurtigtvirkende, ATC kode: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes ,insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutisk klassifikation: Insuliner og analoger til injektion, middelvirkende kombineret med hurtigtvirkende, ATC kode: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutisk klassifikation: Insuliner og analoger til injektion, middelvirkende kombineret med hurtigtvirkende, ATC kode: A10AD01.
Pharmacotherapeutic group: Drugs used in diabetes,insulins and analogues for injection, intermediate-acting combined with fast-acting, ATC Code: A10AD01.
Farmakoterapeutisk klassifikation: Jernkelerende præparat, ATC-kode: V03AC03 Virkningsmekanisme
Pharmacotherapeutic group: Iron chelating agents, ATC code: V03AC03 Mechanism of action
Farmakoterapeutisk klassifikation: Jernkelerende stoffer, ATC-kode: V03AC02 Virkningsmekanisme
Pharmacotherapeutic group: Iron chelating agents, ATC code: V03AC02 Mechanism of action
Farmakoterapeutisk klassifikation: Kolinesterasehæmmer, ATC-kode: N06DA03
Pharmacotherapeutic group: anticholinesterases, ATC code: N06D A03
Farmakoterapeutisk klassifikation: Kønshormoner og modulatorer af genitalsystemet, progesteron- receptormodulatorer.
Pharmacotherapeutic group: Sex hormones and modulators of the genital system, progesterone receptor modulators.
Farmakoterapeutisk klassifikation: Kønshormoner og modulatorer for det genitale system, androgener, ATC-kode: G03BA03
Pharmacotherapeutic group: Sex hormones and modulators of the genital system, androgens, ATC code: G03BA03
Farmakoterapeutisk klassifikation: Lidelser i fordøjelsesorganer og stofskifte, andre midler, ATC- kode: A16AX05.
Pharmacotherapeutic group: various alimentary tract and metabolism products, ATC code: A16AX05.
Farmakoterapeutisk klassifikation: Lipidmodificerende midler, HMG-CoA-reduktasehæmmere i kombination med andre lipidmodificerende midler, ATC-kode: C10BA03
Pharmacotherapeutic group: Lipid modifying agents, HMG CoA reductase inhibitors in combination with other lipid modifying agents, ATC code: C10BA03
Farmakoterapeutisk klassifikation: Lipidmodificerende stoffer, HMG-CoA-reduktase-inhibitorer i kombination med andre lipid-modificerende midler, ATC-kode: C10BA04
Pharmacotherapeutic group: Lipid modifying substances, HMG-CoA reductase inhibitors in combination with other lipid modifying substances, ATC code: C10BA04
Farmakoterapeutisk klassifikation: Lipidregulerende midler, galdesyrebindende midler, ATC-kode: C10A C 04
Pharmacotherapeutic group: Lipid modifying agent, bile acid sequestrants, ATC code: C10A C 04 Mechanism of action
Farmakoterapeutisk klassifikation: Lipidsænkende midler, andre.
Pharmacotherapeutic group: Other lipid modifying agents, plain.
Farmakoterapeutisk klassifikation: Lægemidler anvendt ved erektil dysfunktion.
Pharmacotherapeutic group: Drugs used in erectile dysfunction.
Farmakoterapeutisk klassifikation: Lægemidler til behandling af hyperkaliæmi og hyperfosfatæmi ATC-kode: V03AE08
Pharmacotherapeutic group: Drugs for treatment of hyperkalemia and hyperphosphatemia ATC code: V03AE08
Farmakoterapeutisk klassifikation: Lægemidler til behandling af knoglesygdomme, bisfosfonater, ATC-kode: M05BA08
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates, ATC code: M05 BA 08
Farmakoterapeutisk klassifikation: Lægemidler til brug for behandling af knoglesygdomme, bisfosfonater, ATC-kode: M05BA08.
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates, ATC code: M05BA08
Farmakoterapeutisk klassifikation: Lægemidler til brug ved diabetes, andre blod-glucose sænkende midler, eksklusive insuliner.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins.
Farmakoterapeutisk klassifikation: Lægemidler til brug ved diabetes, andre blodglucosesænkende midler, eksklusive insuliner, ATC-kode: A10BX14.
Pharmacotherapeutic group: Drugs used in diabetes, other blood glucose lowering drugs, excl. insulins, ATC code: A10BX14
Farmakoterapeutisk klassifikation: Lægemidler til diabetes, kombinationer af orale lægemidler til reduktion af blodsukkeret, ATC-kode: A10BD08.
Pharmacotherapeutic group: Drugs used in diabetes, combinations of oral blood glucose lowering drugs, ATC code: A10BD08
Farmakoterapeutisk klassifikation: Lægemidler til obstruktive luftvejslidelser, selektive beta-2- adrenoreceptor agonister, ATC-kode: R03AC18
Pharmacotherapeutic group: Drugs for obstructive airways diseases, selective beta-2-adrenoreceptor agonists, ATC code: R03AC18
Farmakoterapeutisk klassifikation: Lægemidler til obstruktive luftvejssygdomme, adrenergica i kombination med antikolinergika, ATC-kode: R03AL05
Pharmacotherapeutic group: Drugs for obstructive airway diseases, adrenergics in combination with anticholinergics, ATC code: R03AL05
Farmakoterapeutisk klassifikation: Lægemidler til syrerelaterede sygdomme, protonpumpehæmmere, ATC-kode: A02B C05.
Pharmacotherapeutic group: Drugs for acid related disorders, proton pump inhibitors, ATC code: A02B C05.
Farmakoterapeutisk klassifikation: Middel mod anæmi, ATC-kode: B03XA.
Pharmacotherapeutic group: Antianaemic - ATC code: B03XA..
Farmakoterapeutisk klassifikation: Middelhurtigt virkende human insulin-analog.
Pharmaco-therapeutic group: Intermediate acting human insulin analogue.